Neuropharmacological profile of a novel potential atypical antipsychotic drug Y-931

被引：0
|
作者：
Kuriyama, M [1 ]
Hashimoto, K [1 ]
Morimoto, T [1 ]
Tanaka, H [1 ]
Fujimura, M [1 ]
Kimura, K [1 ]
Takehara, S [1 ]
Yasumatsu, H [1 ]
Yamagami, K [1 ]
机构：
[1] Welfide Corp, Div Pharmaceut Res, Drug Discovery Labs, Iruma, Saitama, Japan
来源：
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY | 2002年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：S107 / S108
页数：2
相关论文
共 50 条
  • [41] RGH-1756, a new potential atypical antipsychotic: Receptor profile and effect on prolactin secretion
    Laszlovszky, I
    Csejtei, M
    Lapis, E
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1998, 358 (01) : R58 - R58
  • [42] Paliperidone, a relatively novel atypical antipsychotic drug, is a substrate for breast cancer resistance protein
    Zhou, Yangang
    Li, Huande
    Xu, Ping
    Sun, Li
    Wang, Qing
    Lu, Qiong
    Yuan, Haiyan
    Liu, Yiping
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2018, 16 (06) : 5410 - 5416
  • [43] Screening the 'receptorome' to discover novel proximal molecular targets of atypical antipsychotic drug actions
    Roth, BL
    Meltzer, HY
    Kroeze, WK
    Evans, JM
    Lopez, E
    SCHIZOPHRENIA RESEARCH, 2003, 60 (01) : 314 - 315
  • [44] The effects of the atypical antipsychotic amperozide on vacuous jaw movements in rats: a novel dose response profile
    R. E. Steinpreis
    Lorna Moser
    Fola Parret
    Ethan Rutell
    John Panos
    Psychopharmacology, 1998, 138 : 107 - 113
  • [45] The effects of the atypical antipsychotic amperozide on vacuous jaw movements in rats: a novel dose response profile
    Steinpreis, RE
    Moser, L
    Parret, F
    Rutell, E
    Panos, J
    PSYCHOPHARMACOLOGY, 1998, 138 (02) : 107 - 113
  • [46] Recent advances in novel atypical antipsychotic agents: potential therapeutic agents for the treatment of schizophrenia
    Nakazato, A
    Okuyama, S
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2000, 10 (01) : 75 - 98
  • [47] The synthesis and receptor binding affinities of DDD-016, a novel, potential, atypical antipsychotic
    Bandyopadhyaya, Achintya
    Rajagopalan, Desikan R.
    Rath, Nigam P.
    Herrold, Amy
    Rajagopalan, Raghavan
    Napier, T. Celesete
    Tedford, Clark E.
    Rajagopalan, Parthasarathi
    MEDCHEMCOMM, 2012, 3 (05) : 580 - 583
  • [48] PHARMACOLOGICAL EVALUATION OF HP-370, A POTENTIAL ATYPICAL ANTIPSYCHOTIC AGENT .2. INVITRO PROFILE
    HUGER, FP
    SMITH, CP
    CHIANG, Y
    GLAMKOWSKI, EJ
    ELLIS, DB
    DRUG DEVELOPMENT RESEARCH, 1987, 11 (3-4) : 169 - 175
  • [49] PHARMACOLOGICAL EVALUATION OF HP-370, A POTENTIAL ATYPICAL ANTIPSYCHOTIC AGENT .1. INVIVO PROFILE
    SZEWCZAK, MR
    CORNFELDT, ML
    DUNN, RW
    WILKER, JC
    GEYER, HM
    GLAMKOWSKI, EJ
    CHIANG, Y
    FIELDING, S
    DRUG DEVELOPMENT RESEARCH, 1987, 11 (3-4) : 157 - 168
  • [50] Effective treatment of coprophagia in a patient with schizophrenia with the novel atypical antipsychotic drug perospirone - A case report
    Harada, KI
    Yamamoto, K
    Saito, T
    PHARMACOPSYCHIATRY, 2006, 39 (03) : 113 - 113
12345